Further results from the BANDIT Study
August 2026
Further results from the BANDIT study have been published in Diabetes Care.
Read more
July 31, 2026
ATIC at IDF-WPR, ADC & Metabolic diseases 2026
August 2026
Heading to the 2026 combined IDF-WPR, ADC & Metabolic diseases congress? ATIC is too! Check out our list of must-see presentations.
Read more
June 26, 2026
Novel approaches to metabolic control in diabetes: Multianalyte Sensing and Gene Therapy
Seminar 32, Beyond Insulin Seminar Series – Professor David O’Neal presents novel approaches to metabolic control in diabetes.
Read more
Tzield (Teplizumab) Set to Transform Type 1 Diabetes Care in Australia
May 2026
The approval of Tzield® (teplizumab) by the Therapeutic Goods Administration (TGA) marks the first therapy available to delay the onset of clinical type 1 diabetes.
Read more
SAB-142 Study Shows Positive Early Results in Type 1 Diabetes
May 2026
Early findings from a clinical trial conducted by ATIC in Australia suggest that the immunotherapy MTX‑101 may calm the immune system and help preserve insulin production in people with type 1 diabetes.
Read more
May 28, 2026
Disease-modifying effects of abatacept combined with nasal insulin immunotherapy
Seminar 31, Beyond Insulin Seminar Series – ATIC Lead Investigator, Professor John Wentworth presents findings from the Insulin and Abatacept (IAA) trial.
Read more
Promising early results from MT-101-101 trial
April 2026
Early findings from a clinical trial conducted by ATIC in Australia suggest that the immunotherapy MTX‑101 may calm the immune system and help preserve insulin production in people with type 1 diabetes.
Read more
March 26, 2026
From Narratives to Numbers: The Human Side of Early-Stage Type 1 Diabetes Monitoring and Immunotherapy
Seminar 30, Beyond Insulin Seminar Series – Dr Mia Majstorovic from University of Adelaide presents findings of the QuEST study.
Read more
February 27, 2026
New approaches to measuring beta-cell antigen specific T-cell responses in T1D
Seminar 29, Beyond Insulin Seminar Series – Associate Professor Stuart Mannering from SVI, Melbourne presents his group’s work on the role of T-cells in driving the development of type 1 diabetes and the development of a whole blood assay.
Read more
October 24, 2025
New ATIC video resource
November 2025
The ATIC Community Engagement Panel has led the development of a new video resource designed to raise awareness among health professionals and the community about the benefits of immunotherapy for type 1 diabetes.
Read more
November 27, 2025
Pig Islet Xenotransplantation to Cure T1D
Seminar 28, Beyond Insulin Seminar Series – Professor Peter Cowan from St Vincent’s Hospital, Melbourne and University of Melbourne presents his consortiums’s development of a preclinical pig-to-nonhuman primate (NHP) islet xenograft model.
Read more
October 24, 2025
CiPSC (chemically induced pluripotent stem cell) islet transplantation for T1D
Seminar 27, Beyond Insulin Seminar Series – Professor Hongkui Deng from Peking University in China presents a recent breakthrough using CiPSC (chemically induced pluripotent stem cell) islet transplantation to treat type 1 diabetes
Read more
July 24, 2025
Breakthrough T1D Research Strategy and Clinical Trial Pipeline
Seminar 26, Beyond Insulin Seminar Series – Joshua Vieth from Breakthrough T1D presents an update on the clinical trial pipeline of disease-modifying therapies and the current research strategy for Breakthrough T1D.
Read more
June 27, 2025
Overview of the regulatory process for approval of new Medicines by the Therapeutic Goods Administration (TGA) in Australia
Seminar 25, Beyond Insulin Seminar Series – Helen Critchley: ‘Microbiota orchestrate protective and damaging T cell responses’
Read more
May 22, 2025
Combined presentation
Seminar 24, Beyond Insulin Seminar Series – Jia Yi Hee and M Gayathri from Professor Ranjeny Thomas’ lab at University of Queensland present their PhD research in this combined seminar.
Read more
BASTA – A new assay for early detection of type 1 diabetes
May 2025
Associate Professor Stuart Mannering and his group from St Vincent’s Institute of Medical Research in Melbourne have published their recently developed whole-blood assay to detect early type 1 diabetes.
Read more
March 27, 2025
Microbiota orchestrate protective and damaging T cell responses
Seminar 23, Beyond Insulin Seminar Series – Professor Sammy Bedoui presents: ‘Microbiota orchestrate protective and damaging T cell responses’
Read more
Now Open – MT-101-101 trial for type 1 diabetes
March 2025
The MT-101-101 trial has now commenced and is seeking people age 18-45 years who have been diagnosed with type 1 diabetes. The trial will test the safety and dosing of a new disease-modifying treatment.
Read more
February 28, 2024
Composite Scores to Track Beta Cell Function – Lessons from Islet Cell Transplantation
Seminar 22, Beyond Insulin Seminar Series – Professor Peter Senior presents ‘Composite Scores to Track Beta Cell Function – Lessons from Islet Cell Transplantation’
Read more
SAB-142-101 – New T1D clinical trial
February 2025
ATIC are supporting a new clinical trial seeking people aged 18-45 years who have been diagnosed with type 1 diabetes within the last 5 years. The SAB-142-101 trial will test a potential new ATG treatment for type 1 diabetes.
Read more
ASITI-201 – New clinical trial now open
November 2024
The Princess Alexandra Hospital and University of Queensland are now seeking people aged 18-55 years who have been diagnosed with type 1 diabetes within the last 5 years, for a clinical trial of a new therapy for type 1 diabetes.
Read more
November 21, 2024
Clues to how T cell tolerance prevents T1D progression revelated through clinical trials
Seminar 21, Beyond Insulin Seminar Series – Dr Alice Long presents ‘Clues to how T cell tolerance prevents T1D progression revelated through clinical trials’
Read more
October 25, 2024
Antigen-specific Tregs to treat autoimmune diseases
Seminar 20, Beyond Insulin Seminar Series – A/Prof Joshua Ooi presents ‘Antigen-specific Tregs to treat autoimmune diseases’.
Read more
ATIC Position statement: Use of baricitinib to treat type 1 diabetes
August 2024
The ATIC community engagement panel and steering committee have supported the preparation of a position statement on the use of off-label baricitnib.
Read more
September 26, 2024
Development and deployment of agglutination-PCR testing for islet autoantibodies
Seminar 19, Beyond Insulin Seminar Series – A/Prof John Wentworth presents ‘Development and deployment of agglutination-PCR testing for islet autoantibodies’.
Read more
Care pathways for people with early-stage type 1 diabetes in Australia
July 2024
A group of ATIC clinician-researchers with support from JDRFA have published the Australian guidelines “Care pathways for people with early-stage type 1 diabetes in Australia”.
Read more
July 25, 2024
Making a National Screening Program for Type 1 Diabetes a Reality in Australia: Progress and Plans
Seminar 18, Beyond Insulin Seminar Series – Dr Kirstine Bell presents ‘Making a National Screening Program for Type 1 Diabetes a Reality in Australia: Progress and Plans’
Read more
May 23, 2024
Measuring what matters: psychosocial and behavioural outcomes in T1D trials
Seminar 16, Beyond Insulin Seminar Series – Dr Elizabeth Holmes-Truscott present ‘Measuring what matters: the assessment of psychosocial and behavioural outcomes in type 1 diabetes trials’.
Read more June 28, 2024
Clinical translation of antigen-specific immunotherapy for type 1 diabetes – from discovery to clinical trials
Seminar 17, Beyond Insulin Seminar Series – Professor Ranjeny Thomas talk about ‘clinical translation of antigen-specific immunotherapy for type 1 diabetes’.
Read more
April 26, 2024
PANDA (Pan autoantibody negative diabetes in adults) study
Seminar 15, Beyond Insulin Seminar Series – Dr Shivani Patel from the Garvan Institute of Medical Research will present ‘PANDA (Pan autoantibody negative diabetes in adults) study’.
Read more
March 28, 2024
Lessons from a failed coeliac disease trial: a new way forwards?
Seminar 14, Beyond Insulin Seminar Series – Associate Professor Jason Tye-Din from WEHI will present ‘Lessons from a failed coeliac disease trial: a new way forwards?’
Read more
February 23, 2024
Using Type 1 Diabetes Genetic Risk Scores for Prediction and Diagnosis of Type 1 Diabetes
Seminar 13, Beyond Insulin Seminar Series – Dr Maria Redondo from Baylor College of Medicine, Houston, Texas provides an update on T1D Genetic Risk Scores in T1D
Read more
November 23, 2023
Research breakthrough
December 2023
In a world-first, ATIC researchers lead by Professor’s Thomas Kay and Helen Thomas have shown that baricitinib, an immunotherapy treatment commonly used in rheumatoid arthritis, can delay the progression of type 1 diabetes…
Read more
November 23, 2023
CD47 – more than just a receptor on islets
Seminar 12 in the Beyond Insulin Seminar Series will be a summary of the findings from a recent discovery in CD47 receptors and type 1 diabetes by Professor Natasha Rogers (Westmead Hospital).
Read more
October 27, 2023
Checkpoint inhibitor related autoimmune diabetes: from bench to bedside
Seminar 11 – Beyond Insulin Seminar Series, Dr Linda Wu from Westmead Institute for Medical Research provides an update on current knowledge around checkpoint inhibitor related diabetes
Read more
T1D RELAY – New clinical trial now open
September 2023
ATIC and The Royal Melbourne Hospital are now seeking people aged 8-45 years with recently diagnosed type 1 diabetes (within three months) for a new clinical trial of two disease-modifying medications rituximab-pvvr and abatacept, called T1D RELAY.
Read more
September 21, 2023
Who killed my beta cells and why did they do it?
Seminar 10 of the Beyond Insulin Seminar Series features Associate Professor Stuart Mannering who will discuss one of the fundamental outstanding questions in the immunology of T1D – how and why does the immune system attack the insulin producing cells?
Read more
July 27, 2023
Role of the gut microbiota in T1D
Seminar 9 of the Beyond Insulin Seminar Series features Associate Professor Emma Hamilton-Williams. A/Prof Hamilton-Williams will discuss results from a clinical trial that aimed to restore a ‘healthy’ gut microbiota in adults with type 1 diabetes.
Read more
All trial sites for the Nasal Insulin and Abatacept (IAA Trial) are now open
June 2023
For the first time in Australia, researchers will carry out a type 1 diabetes trial to test two different immune therapies in children and young adults who have been recently diagnosed with type 1 diabetes.
Read more
April 28, 2023
Viral aetiology of type 1 diabetes
7th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
Read more
Verapamil in type 1 diabetes
March 2023
The human immune system works every minute of every day to keep the body healthy – through constant monitoring, and by tracking and destroying pathogens, such as disease-causing bacteria and viruses.
Read more
March 23, 2023
Continuous glucose monitoring in children at risk of type 1 diabetes
6th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
Read more
February 22, 2023
ATIC Town Hall Forum – video now available
ATIC recently invited members of the type 1 diabetes community to learn more about ATIC – the first Australasian clinical trial collaborative set up to accelerate development and delivery of immunotherapy treatments.
Read more
February 24, 2023
Baricitinib in the Treatment of Alopecia Areata
5th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
Read more
IAA clinical trial now open for recruitment
January 2023
ATIC is now seeking participants aged between 6 and 21 years with newly diagnosed type 1 diabetes for a ground-breaking Australian clinical trial.
Read more
Community Engagement Panel – calling for expressions of interest
November 2022
ATIC is seeking expressions of interest from members of the type 1 diabetes community who are interested in joining our Community Engagement Panel.
Read more October 28, 2022
Benchmarking cells for beta cell replacement therapies
3rd seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
Read more September 29, 2022
Harnessing T cell exhaustion to treat autoimmune disease
2nd seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
Read more August 26, 2022
New ATIC Seminar Series: commencing 26th August 2022
Introducing ATIC’s new seminar series ‘Beyond Insulin: Innovative research in T1D prevention and cure’. Join us for a new session each month!
Read more
August 10, 2022
August ATIC launch at Australian Diabetes Congress
We’re very excited to be officially launching ATIC at the upcoming ADC 2022 in Brisbane.
Read more
ATIC Steering Committee meet for the first time
April 2022
Leading diabetes clinicians and researchers from across Australia gathered recently for the first meeting of the Australasian Type 1 Diabetes Immunotherapies Collaborative (ATIC) Steering Committee.
Read more
Immunotherapy: harnessing our immune system against disease
March 2022
The human immune system works every minute of every day to keep the body healthy – through constant monitoring, and by tracking and destroying pathogens, such as disease-causing bacteria and viruses.
Read more
IMPACT trial commences in Australia
February 2022
In collaboration with Innodia, the ATIC network is leading IMPACT, a trial of a new medication called IMCY-0098 to determine whether it can preserve pancreas function in people with newly diagnosed type 1 diabetes.
Read more
BANDIT trial filled
January 2022
Thanks to the generosity of the type 1 diabetes community, we have completed recruitment for the BANDIT trial.
Read more
Collaborative focused on immunotherapy in type 1 diabetes – ANZ first
January 2022
JDRF Australia has funded a first-of-its kind four-year collaboration, aimed at increasing the number of clinical trials available for Australians with type 1 diabetes.
Read more